Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

about

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

Item

http://www.wikidata.org/entity/Q47552518

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@en

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@nl

type

Item

label

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@en

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@nl

prefLabel

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@en

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

@nl

P1476

Sedative Plasma Concentrations and Delirium Risk in Critical Illness

@en

P2093

Ayumi K Shintani

http://www.w3.org/2001/XMLSchema#string

Benjamin A Ferrell

http://www.w3.org/2001/XMLSchema#string

Christopher G Hughes

http://www.w3.org/2001/XMLSchema#string

Grant R Wilkinson

http://www.w3.org/2001/XMLSchema#string

Jennifer L Thompson

http://www.w3.org/2001/XMLSchema#string

Joanna L Stollings

http://www.w3.org/2001/XMLSchema#string

Pratik P Pandharipande

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of increasing plasma concentrations of dexmedetomidine in humans

Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU).

A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.

Long-term cognitive impairment after critical illness.

Outcome of delirium in critically ill patients: systematic review and meta-analysis

Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial

Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.

Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients.

Prevalence and risk factors for development of delirium in burn intensive care unit patients.

P304

513-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028017753480

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29363356

http://www.w3.org/2001/XMLSchema#string

P932

5930024

http://www.w3.org/2001/XMLSchema#string